(Q54124940)
Statements
Phase 2 trial of single agent ifosfamide/mesna in patients with platinum/paclitaxel refractory ovarian cancer who have not previously been treated with an alkylating agent. (English)
1 reference
Markman M
1 reference
Kennedy A
1 reference
Sutton G
1 reference
Hurteau J
1 reference
Webster K
1 reference
Peterson G
1 reference
Kulp B
1 reference
Belinson J
1 reference
1 August 1998
1 reference
70
1 reference
272-274
1 reference
2
1 reference
Identifiers
1 reference